Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England

por Rothwell, Ben, Kiff, Christopher, Ling, Caroline, Brodtkorb, Thor-Henrik
Publicado 2020

Value of information: interim analysis of a randomized, controlled trial of goal-directed hemodynamic treatment for aged patients

por Bartha, Erzsebet, Davidson, Thomas, Brodtkorb, Thor-Henrik, Carlsson, Per, Kalman, Sigridur
Publicado 2013

The Budget Impact of Introducing Tildrakizumab to a United States Health Plan for Managing Moderate-to-Severe Plaque Psoriasis

por Carrico, Justin, Zhao, Yang, Jia, Xiaoying, Brodtkorb, Thor-Henrik, Mendelsohn, Alan, Lowry, Simon
Publicado 2020

Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review

por Brockbank, James, Krause, Taryn, Moss, Emily, Pedersen, Anne Milthers, Mørup, Michael Frank, Ahdesmäki, Outi, Vaughan, Jake, Brodtkorb, Thor-Henrik
Publicado 2021

The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very hi...

por Laramée, Philippe, Brodtkorb, Thor-Henrik, Rahhali, Nora, Knight, Chris, Barbosa, Carolina, François, Clément, Toumi, Mondher, Daeppen, Jean-Bernard, Rehm, Jürgen
Publicado 2014